Austin, TX — April 27, 2026 — RxFoundry, a developer of innovative pharmacy software solutions, today announced the licensing of its SwiftyRx platform to support direct to employer programs at Centerwell.
From the formal release:
"As part of the collaboration [between CenterWell and Mark Cuban Cost Plus Drugs], CenterWell Pharmacy, which employs more than 500 pharmacists who provide around-the-clock patient support, will be a pharmacy partner of Cost Plus Drugs. In addition, Cost Plus Drugs digital pharmacy’s 'software as a service' or 'SaaS' solution, SwiftyRx, will be used by CenterWell Pharmacy for its medication order intake operations."
See the full press releases at: